How to Pronounce Wegovy — and Why the Name Trips Everyone Up

The myth that's worth correcting first: Wegovy and Ozempic aren't different drugs

A common piece of confusion circulating online is that Wegovy and Ozempic are essentially the same medicine sold under two names for marketing reasons. The pronunciation question often comes bundled with this one, people hear 'Ozempic' constantly in the news, then see 'Wegovy' on a UK pharmacy and wonder if they're asking for the same thing.

They do share the same molecule, semaglutide, but they are not interchangeable in the UK. Ozempic is licensed here for type 2 diabetes. Wegovy is the formulation licensed for weight management, at a higher maintenance dose and following a different titration schedule. The semaglutide overview on this site explains the distinction in full. For now, the practical point is this: if a UK prescriber or pharmacist says 'Wegovy', they specifically mean the weight-management product, not the diabetes one. Getting the name right matters for exactly that reason.

Pronouncing it correctly (WEE-go-vee) also helps when you're speaking to a GP, a pharmacist, or calling a clinic, and if you want to hear it broken down syllable by syllable, the Wegovy pronunciation guide on this site walks you through it. A quick way to check your own pronunciation: say 'free' out loud, then place 'WEE-go' in front of it. Run through it twice and it settles.

How semaglutide got its name, and how to say it confidently

Pharmaceutical naming follows conventions set by the World Health Organisation's International Nonproprietary Names programme. The suffix '-glutide' is the INN stem for GLP-1 receptor agonist peptides. That is why you also hear liraglutide, dulaglutide and others ending the same way.

Broken into four parts, semaglutide runs: SEM (like the word 'sem' in 'semester') (ah (a short, unstressed vowel)) GLOO (rhymes with 'blue'), tide (exactly as in the sea). Say it slowly once, then again at normal speed, and the rhythm usually clicks. The NHS patient information page for semaglutide is a reliable reference if you want to cross-check clinical terminology before a medical appointment.

If you have been researching starting Wegovy and feel unsure what to call it when you speak to a clinician, the answer is simply: either name works. Prescribers hear both every day. What matters far more to them is your medical history, current medications and weight-related health conditions, the substance of the consultation, not the pronunciation.

Brand name, generic name, and one more name to know

There is a third name that sometimes appears: Ozempic, discussed above. But there is also a newer arrival. As of summer 2026, Wegovy is available in two UK-licensed forms: the weekly injection and a daily tablet, each with the same active ingredient but a different formulation, dose and routine. The tablet version uses an absorption enhancer to allow semaglutide to survive the digestive system, a genuine engineering challenge given that semaglutide was originally designed as an injection. Both carry the Wegovy brand name in the UK.

Understanding the trade-offs of each form is worth doing before a consultation, since the right choice depends on factors like your tolerance for injections, your morning routine and any other medicines you take. That question sits firmly with a prescriber. What you can do before that conversation is arrive knowing the names (brand and generic) and roughly what you are asking about.

For context on what private treatment involves financially, the Wegovy cost page covers UK pricing transparently, including what is typically included in a legitimate private prescription and what questions to ask any provider. Cost is one part of the picture; clinical safety is another, and they are not always in tension if you choose the right route.

A note on the new 7.2mg pen and why correct naming matters practically

In April 2026 the MHRA approved a single-dose 7.2mg Wegovy pen, a higher maintenance dose delivered via a dedicated device. The MHRA's announcement confirmed this is licensed only for adults with a BMI of 30 or above, and the starting dose remains 0.25mg regardless, titrated upward by the prescriber.

The reason naming precision matters here: the 7.2mg dose is specific to Wegovy for weight management and does not exist in the Ozempic product range. If you read about it online and then call a pharmacy asking for 'the new 7.2mg pen', being clear that you mean Wegovy rather than Ozempic avoids any confusion over which product is being discussed. A prescriber will clarify this anyway, but arriving informed makes the conversation shorter and more productive.

Wegovy is a prescription-only medicine in the UK. A clinician (not an automated system) reviews your consultation before any prescription is issued. If you are weighing up whether it might be suitable, checking your eligibility is the natural next step, and it is free to do.